Search results
- The Cincinnati Children’s Division of Oncology is an international leader in caring for children and young adults with cancer. We are experts in treating and curing the hardest, most resistant cancers.
www.cincinnatichildrens.org/service/c/cancer
People also ask
Who is Cincinnati Children's division of Oncology?
Why should you choose Cincinnati Children's Cancer?
What is the division of neonatology at Cincinnati Children's?
Who are the doctors at Cincinnati Children's Hospital?
How many people work at Cincinnati Children's Hospital Medical Center?
Who is the director of the division of Oncology?
Meet Our Division of Oncology Specialists. The Division of Oncology is home to cancer specialists with a wide variety of backgrounds and areas of focus. As a team, this diversity makes us better prepared to care for you or your child's unique needs. Learn more about our faculty and staff.
- Oncology
Cancer and leukemia biology research, with integrated new...
- Cancer Program
John Perentesis, MD, FAAP, Director of the Division of...
- Cincinnati Children's
The Cincinnati Children’s Division of Oncology is an...
- Oncology
- Team Approach to Develop New Treatments For The Hardest-To-Treat Cancers
- Pioneers in Next-Generation Sequencing
- Experienced Cellular and Immunotherapy Program
- Cutting-Edge Radiation Therapy
- Internationally Recognized Bone Marrow Transplant Program
- Preserving Fertility For Patients’ Adult Years
- Young Adult Cancer Center
- Survivorship and Lifelong Wellness
- Expert Second Opinions
Our clinical and research teams often develop new treatments for the most difficult-to-treat cancers. This “team science” led to the recent pediatric Food and Drug Administration (FDA) approvals of the new drugs Vyxeos for acute myeloid leukemia, and selumetinib for patients with inoperable neurofibromatosis tumors.
We were innovators in the use of “next generation sequencing," which helps us to understand the genetic wiring of cancers and leukemias that have not responded to traditional therapies. We can now tailor treatments to those cancers with targeted drugs and immune therapies.
Chimeric antigen receptor (CAR) T-cell therapy uses a patient’s own immune system to kill aggressive and treatment-resistant cancers. Cincinnati Children’s is among the most experienced in the country with many options for leukemia and lymphoma, giving more children the opportunity to benefit from this lifesaving therapy. We are developing other ne...
Our Proton Therapy Centerdelivers the most advanced form of radiation therapy available. This technology destroys cancer cells while minimizing damage to surrounding healthy tissues and organs, and has fewer side effects to the brain.
Our specialized Bone Marrow Transplant Programhas performed more than 2,300 pediatric marrow and stem cell transplants. The team helped develop stem cell transplant procedures that are the standard of care in more than 200 cancer centers throughout North America.
As a global leader in fertility preservation, we work to protect a patient’s ability to have biological children later in life. Our Comprehensive Fertility Care and Preservation Programprovides consultations to every patient. They have services and treatments to preserve fertility in all ages from infancy to adulthood.
Our Young Adult Cancer Centeris internationally recognized as a pioneer in developing precision therapies for young adult patients with forms of pediatric cancers. We’ve developed protocols to treat these patients who react to cancer therapies much differently than their younger and older counterparts.
Our Cancer Survivorship Centerprovides specialized medical care and psychosocial support to childhood cancer survivors continuously and without interruption through adulthood.
Cincinnati Children’s provides second opinions for children and young adults with cancer, with an emphasis on high-risk or treatment-resistant cancers. Second opinions help you understand all of the available treatment options and make a more informed decision about which therapy is best. Learn more about the benefits of a second opinionand how to ...
Cancer and leukemia biology research, with integrated new drug and molecular therapies discovery focused on pediatric malignancies. Personalized cancer therapy approaches using tumor molecular signatures and individualized patient pharmacogenomics. New gene, viral and cellular therapies.
John Perentesis, MD, FAAP, Director of the Division of Oncology is a nationally recognized expert in the development of new drugs and molecular therapies for pediatric and young adult cancers and leukemia.
Cincinnati Children's Hospital Medical Center (CCHMC) is an academic pediatric acute care children's hospital located in the Pill Hill neighborhood of Cincinnati, Ohio. The hospital has 652 pediatric beds [1] and is affiliated with the University of Cincinnati Academic Health Center.
Nov 7, 2023 · Cincinnati Children’s has been recognized by Becker’s Hospital Review for being a national leader in providing outstanding cancer care as well as for accelerating innovation by conducting research that includes world-first clinical trials.
Sep 26, 2023 · Cincinnati Children’s formed the Advanced Leukemia Therapies and Research Center to accelerate more scientific discoveries like this to bring more curative options to AML patients. The center builds on a foundation of ongoing, groundbreaking research.
